allergic reactions to semaglutide Why Injection Sites Burn: Causes & Relief Side Effects of Semaglutide

The LEADER trial enrolled patients with T2DM and high cardiovascular risk, defined as established CVD (81%) or age 60 years with at least one risk factor, and showed that liraglutide significantly reduced the incidence of 3-point major adverse cardiovascular events (MACE) (i.e., CV death, non-fatal myocardial infarction, non-fatal stroke) by 13% compared to placebo (HR 0.87

Therefore, these injections should be administered by a healthcare professional who can monitor for adverse reactions and adjust treatment as necessary

Separate clinical trials suggest similar weight loss results, but the studies were not designed as a head-to-head comparison

Users typically experience side effect stabilization within 48 weeks